Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
LFST	LIFESTANCE HEALTH GROUP INC	United States	$2.36B	380,689,929	32.64%	67.36%	Net Selling	Net Selling
PRPO	PRECIPIO INC	United States	$8.62M	1,430,292	0.61%	99.39%	Net Buying	Net Buying
PSNL	PERSONALIS INC	United States	$63.89M	50,503,889	43.52%	18.39%	Net Selling	Net Buying
HOTH	HOTH THERAPEUTICS INC	United States	$5.11M	4,403,804	0.94%	99.06%
LSTA	LISATA THERAPEUTICS INC	United States	$22.00M	8,307,433	0.84%	99.16%	Net Selling
EMBC	EMBECTA CORP	United States	$593.64M	57,578,921	96.14%	1.52%	Net Selling	Net Selling
ACB	AURORA CANNABIS INC	Canada	$318.86M	47,590,382	54.59%	0.00%
CTKB	CYTEK BIOSCIENCES INC	United States	$753.55M	130,824,069	60.34%	21.49%	Net Selling	Net Selling
OPRX	OPTIMIZERX CORP	United States	$184.02M	18,183,914	52.76%	47.24%	Net Selling	Net Selling
ETON	ETON PHARMACEUTICALS INC	United States	$88.62M	25,688,062	27.87%	21.84%
YMAB	Y-MABS THERAPEUTICS INC	United States	$643.96M	43,777,105	46.22%	39.32%	Net Buying	Net Selling
ABSI	ABSCI CORP	United States	$516.55M	112,784,576	29.91%	39.04%	Net Buying	Net Buying
NEPH	NEPHROS INC	United States	$23.09M	10,543,675	5.62%	94.38%	Net Buying	Net Buying
BEAM	BEAM THERAPEUTICS INC	United States	$1.75B	81,657,714	78.57%	21.43%	Net Selling	Net Selling
BLUE	BLUEBIRD BIO INC	United States	$100.92M	109,336,211	91.17%	8.83%	Net Selling	Net Selling
AUGX	AUGMEDIX INC	United States	$138.91M	48,739,739	32.25%	67.75%	Net Selling	Net Selling
SILK	SILK ROAD MEDICAL INC	United States	$697.31M	39,174,619	83.32%	16.68%	Net Selling	Net Selling
MTEM	MOLECULAR TEMPLATES INC	United States	$9.16M	5,374,268	1.90%	98.10%	Net Buying	Net Buying
ARVN	ARVINAS INC	United States	$2.20B	68,083,928	74.74%	25.26%	Net Selling	Net Selling
BAX	BAXTER INTERNATIONAL INC	United States	$20.38B	507,827,437	84.81%	15.19%	Net Selling	Net Selling
LQDA	LIQUIDIA CORP	United States	$952.63M	76,027,776	37.70%	62.30%	Net Buying	Net Selling
MESO	MESOBLAST LTD	Australia	$633.23M	1,014,799,334	0.14%	0.00%
NTRA	NATERA INC	United States	$11.07B	120,757,877	78.43%	21.57%	Net Selling	Net Selling
ATAI	ATAI LIFE SCIENCES NV	United States	$320.43M	166,026,396	7.99%	37.92%	Net Selling	Net Selling
XGN	EXAGEN INC	United States	$24.34M	17,235,751	36.96%	63.04%	Net Selling	Net Selling
GLMD	GALMED PHARMACEUTICALS LTD	Israel	$1.98M	5,045,324	10.84%	0.00%
HLTH	CUE HEALTH INC	United States	$22.35M	158,516,303	38.15%	55.22%	Net Selling	Net Selling
AUPH	AURINIA PHARMACEUTICALS INC	Canada	$710.07M	144,617,762	36.80%	3.18%	Net Selling	Net Selling
EXAS	EXACT SCIENCES CORP	United States	$10.68B	181,530,967	88.62%	3.40%	Net Selling	Net Selling
INVO	INVO BIOSCIENCE INC	United States	$2.69M	2,743,031	3.87%	96.13%
CRBU	CARIBOU BIOSCIENCES INC	United States	$335.07M	90,314,501	76.47%	8.74%	Net Buying	Net Buying
CASI	CASI PHARMACEUTICALS INC	China	$32.38M	13,378,175	0.35%	99.65%
MOLN	MOLECULAR PARTNERS AG	Switzerland	$127.47M	32,854,297	2.91%	0.00%
SPRC	SCISPARC LTD	Israel	$1.45M	1,095,784	0.68%	0.00%
LYEL	LYELL IMMUNOPHARMA INC	United States	$551.39M	254,096,311	51.66%	46.21%	Net Selling
AMWL	AMERICAN WELL CORP	United States	$152.73M	289,252,593	49.86%	9.79%	Net Selling	Net Selling
EGRX	EAGLE PHARMACEUTICALS INC	United States	$54.03M	12,986,971	23.18%	76.82%	Net Selling	Net Selling
XOMA	XOMA CORP	United States	$295.41M	11,625,826	17.69%	82.31%	Net Buying
HCA	HCA HEALTHCARE INC	United States	$81.12B	264,498,700	10.80%	89.20%	Net Selling	Net Selling
ALLO	ALLOGENE THERAPEUTICS INC	United States	$488.68M	169,091,992	60.42%	39.58%	Net Selling	Net Selling
TLRY	TILRAY BRANDS INC	Canada	$1.38B	774,028,558	8.97%	1.99%	Net Buying
TARS	TARSUS PHARMACEUTICALS INC	United States	$1.10B	34,218,886	66.40%	33.60%	Net Selling	Net Selling
CODX	CO-DIAGNOSTICS INC	United States	$34.70M	31,259,668	14.99%	27.92%	Net Selling
JYNT	JOINT CORP	United States	$180.71M	14,776,243	56.38%	43.62%	Net Buying
PRTC	PURETECH HEALTH PLC	United States	$774.78M	271,853,731	0.00%	0.00%
KROS	KEROS THERAPEUTICS INC	United States	$2.08B	35,982,628	70.92%	29.08%	Net Buying
INO	INOVIO PHARMACEUTICALS INC	United States	$247.02M	23,370,365	61.56%	38.44%	Net Selling	Net Selling
MRNS	MARINUS PHARMACEUTICALS INC	United States	$76.77M	54,642,580	81.93%	18.07%	Net Buying	Net Buying
ZYXI	ZYNEX INC	United States	$360.63M	32,170,182	29.68%	49.40%	Net Selling	Net Selling
WRBY	WARBY PARKER INC	United States	$1.53B	118,162,796	48.64%	51.36%	Net Selling	Net Selling
IKNA	IKENA ONCOLOGY INC	United States	$62.74M	48,258,111	66.60%	18.22%
QTTB	Q32 BIO INC	United States	$90.49M	3,229,641	47.15%	52.85%	Net Selling	Net Selling
ARQT	ARCUTIS BIOTHERAPEUTICS INC	United States	$820.01M	96,813,363	73.15%	26.85%	Net Buying	Net Selling
PGEN	PRECIGEN INC	United States	$350.98M	248,919,096	25.15%	73.06%	Net Buying	Net Selling
LIVN	LIVANOVA PLC	United Kingdom	$3.00B	53,956,158	90.86%	9.14%	Net Selling	Net Selling
PNTG	PENNANT GROUP INC	United States	$623.66M	30,012,588	85.43%	8.92%	Net Buying	Net Buying
IMNM	IMMUNOME INC	United States	$819.60M	59,694,243	36.00%	9.90%	Net Buying
CUE	CUE BIOPHARMA INC	United States	$66.40M	48,643,316	30.60%	9.31%	Net Buying
PLUR	PLURI INC	Israel	$27.78M	5,185,022	0.58%	99.42%
CCCC	C4 THERAPEUTICS INC	United States	$423.27M	68,600,669	68.39%	25.32%	Net Buying	Net Selling
DRIO	DARIOHEALTH CORP	Israel	$43.57M	29,442,532	29.42%	53.98%
GTHX	G1 THERAPEUTICS INC	United States	$208.28M	52,199,394	24.18%	47.08%	Net Selling	Net Selling
MASS	908 DEVICES INC	United States	$186.60M	32,909,929	58.33%	41.67%	Net Selling	Net Buying
GLYC	GLYCOMIMETICS INC	United States	$105.70M	64,450,385	35.53%	64.47%	Net Buying	Net Buying
NPCE	NEUROPACE INC	United States	$379.53M	28,344,637	29.97%	70.03%	Net Selling	Net Selling
BNGO	BIONANO GENOMICS INC	United States	$42.99M	54,694,000	11.29%	47.22%	Net Buying	Net Selling
OLK	OLINK HOLDING AB (PUBL)	Sweden	$2.84B	124,342,715	30.18%	0.00%
MIST	MILESTONE PHARMACEUTICALS INC	Canada	$81.85M	53,149,778	33.44%	24.16%
NTLA	INTELLIA THERAPEUTICS INC	United States	$2.00B	96,106,405	68.92%	31.08%	Net Selling	Net Selling
SWTX	SPRINGWORKS THERAPEUTICS INC	United States	$3.36B	73,786,845	64.08%	35.92%	Net Selling	Net Selling
PACB	PACIFIC BIOSCIENCES OF CALIFORNIA INC	United States	$393.89M	267,951,880	92.99%	7.01%	Net Buying	Net Buying
FLGT	FULGENT GENETICS INC	United States	$598.67M	29,784,771	48.02%	42.49%	Net Selling	Net Selling
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	United States	$5.86M	1,356,626	1.45%	3.94%	Net Buying
SRPT	SAREPTA THERAPEUTICS INC	United States	$12.09B	93,855,410	73.88%	26.12%	Net Buying	Net Selling
ABCL	ABCELLERA BIOLOGICS INC	Canada	$1.10B	292,782,152	40.68%	47.55%	Net Buying	Net Buying
DNLI	DENALI THERAPEUTICS INC	United States	$2.15B	139,160,239	56.52%	43.48%	Net Selling	Net Selling
QURE	UNIQURE NV	Netherlands	$216.71M	47,838,275	78.37%	13.99%	Net Selling	Net Selling
CLOV	CLOVER HEALTH INVESTMENTS CORP	United States	$336.80M	495,292,461	19.47%	25.59%	Net Selling	Net Selling
LYRA	LYRA THERAPEUTICS INC	United States	$281.99M	59,743,123	70.88%	14.48%	Net Buying
GBIO	GENERATION BIO CO	United States	$192.78M	66,477,111	63.23%	36.77%	Net Buying	Net Selling
MXCT	MAXCYTE INC	United States	$386.32M	104,128,650	62.67%	11.15%	Net Buying	Net Buying
ALEC	ALECTOR INC	United States	$502.68M	95,749,259	57.86%	42.14%	Net Selling	Net Selling
OVID	OVID THERAPEUTICS INC	United States	$219.20M	70,709,857	62.41%	23.75%	Net Buying	Net Buying
LUMO	LUMOS PHARMA INC	United States	$22.46M	8,107,121	17.70%	82.30%	Net Buying	Net Buying
COCP	COCRYSTAL PHARMA INC	United States	$15.82M	10,173,790	0.69%	99.31%
CVKD	CADRENAL THERAPEUTICS INC	United States	$6.88M	16,008,469	3.45%	46.72%	Net Buying
PALI	PALISADE BIO INC	United States	$5.15M	851,401	3.08%	96.92%	Net Buying	Net Buying
INVA	INNOVIVA INC	United States	$964.85M	63,227,333	58.68%	41.32%	Net Buying	Net Buying
UPC	UNIVERSE PHARMACEUTICALS INC	China	$7.95M	3,645,974	0.18%	0.00%
SLRN	ACELYRIN INC	United States	$417.07M	98,365,050	73.07%	26.93%	Net Buying	Net Selling
SMTI	SANARA MEDTECH INC	United States	$278.95M	8,622,805	0.53%	99.47%	Net Selling	Net Selling
HBIO	HARVARD BIOSCIENCE INC	United States	$157.11M	43,399,291	51.38%	48.62%	Net Selling	Net Selling
ACRS	ACLARIS THERAPEUTICS INC	United States	$85.11M	70,925,042	56.85%	43.15%	Net Selling	Net Selling
BMY	BRISTOL MYERS SQUIBB CO	United States	$90.92B	2,027,100,096	76.28%	0.36%	Net Selling	Net Selling
HCAT	HEALTH CATALYST INC	United States	$353.13M	58,563,005	74.87%	25.13%	Net Selling	Net Selling
SXTP	60 DEGREES PHARMACEUTICALS INC	United States	$2.75M	11,570,578	4.00%	31.34%	Net Buying	Net Buying
NGNE	NEUROGENE INC	United States	$385.08M	12,852,985	36.48%	63.52%	Net Buying
PPBT	PURPLE BIOTECH LTD	Israel	$9.72M	198,386,080	1.23%	0.00%
GHSI	GUARDION HEALTH SCIENCES INC	United States	$10.14M	1,284,156	0.40%	99.60%
ALPN	ALPINE IMMUNE SCIENCES INC	United States	$4.23B	65,546,136	59.43%	40.57%	Net Buying

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	682	+1.20%	+1.13%	-9.62%	-22.18%	14.88x	5.85x	-68.98%	+2.75%	+21.30%	+91.72%	Strong Buy
Diagnostics & Research	66	+0.75%	+4.09%	-5.10%	-0.74%	38.49x	4.18x	-21.75%	+6.53%	+11.20%	+10.85%	Buy
Drug Manufacturers - General	17	+0.34%	+1.38%	-4.08%	+12.78%	159.81x	6.13x	+32.60%	+7.65%	+14.35%	+15.95%	Buy
Drug Manufacturers - Specialty & Generic	90	+0.98%	+2.24%	-2.72%	-6.94%	33.92x	2.09x	+11.56%	+2.78%	+5.22%	+37.77%	Strong Buy
Healthcare Plans	12	-0.85%	-2.11%	-4.78%	+3.59%	18.86x	2.91x	+20.02%	+6.15%	+14.19%	+16.44%	Buy
Health Information Services	61	+0.87%	+0.45%	-8.40%	-24.77%	72.49x	3.38x	+6.61%	+2.33%	+5.91%	+38.22%	Buy
Medical Care Facilities	50	-0.63%	-0.25%	-6.53%	+3.06%	-1.17x	4.49x	-87.35%	+6.17%	+13.08%	+19.34%	Buy
Medical Devices	154	+0.28%	+1.14%	-4.31%	-15.96%	28.63x	3.70x	+10.75%	+5.35%	+7.78%	+22.71%	Buy
Medical Distribution	9	+0.52%	+1.70%	-0.69%	+37.51%	26.24x	147.94x	+18.14%	+3.52%	+19.64%	+3.58%	Buy
Medical Instruments & Supplies	56	+1.23%	+1.70%	-4.37%	-11.53%	48.29x	3.53x	+11.70%	+7.83%	+10.36%	+19.66%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top healthcare stock with a Zen Score of 75, which is 50 points higher than the healthcare sector average of 25. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.72% over the past year, underperforming other healthcare stocks by -20 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.53% from Incyte's current stock price of $51.68.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -7.45% over the past year, overperforming other healthcare stocks by 3 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.33% from Harmony Biosciences Holdings's current stock price of $29.32.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -0.61% over the past year, overperforming other healthcare stocks by 10 percentage points.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.84%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.38%, which is 55 percentage points higher than the healthcare sector average of 2.84%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.95%, which is 9 percentage points higher than the healthcare sector average of 2.84%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.62% in the last day, and up 1.39% over the last week. Biodexa Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 79.31% yesterday.

Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -53.19% in the past year. It has underperformed other stocks in the healthcare sector by -43 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -40.25% in the past year. It has underperformed other stocks in the healthcare sector by -30 percentage points.

3. Orasure Technologies (NASDAQ:OSUR)

Orasure Technologies (NASDAQ:OSUR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Orasure Technologies has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Orasure Technologies's stock has dropped -19.88% in the past year. It has underperformed other stocks in the healthcare sector by -10 percentage points.

Are healthcare stocks a good buy now?

47.45% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.39% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 74.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.